KCa3.1/KCa2.3 potassium channels as target structures in cerebro-cardiovascular disease, metabolic syndrome, organ fibrosis. “Proof-of-Concept-Trials”.
Publicado en:
1. Hasenau AL, Nielsen G, Morisseau C, Hammock BD, Wulff H, Köhler R. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+-activated K+-channels. Acta Physiol (Oxf) 203(1):117-26, 2011.
2. Schmidt K, Dubrovska G, Nielsen G, Fesüs G, Uhrenholt TR, Hansen PH, Gudermann T, Dietrich A, Gollasch M, de Wit C, Köhler R. Amplification of EDHF-type vasodilatations in TRPC1-deficient mice. Brit J Pharmacol 161(8):1722-33, 2010.
Author:
Köhler , Ralf
Principal researcher:
Ralf Köhler
Scope:
Internacional
Entidades participantes:
Unversidad Aarhus y SDU, Dinamarca; Universidad de California Davis, U.S:A
Publicado en:
1. Hasenau AL, Nielsen G, Morisseau C, Hammock BD, Wulff H, Köhler R. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+-activated K+-channels. Acta Physiol (Oxf) 203(1):117-26, 2011.
2. Schmidt K, Dubrovska G, Nielsen G, Fesüs G, Uhrenholt TR, Hansen PH, Gudermann T, Dietrich A, Gollasch M, de Wit C, Köhler R. Amplification of EDHF-type vasodilatations in TRPC1-deficient mice. Brit J Pharmacol 161(8):1722-33, 2010.